These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 21108201)

  • 1. [ Upgrading of cardiac resynchronization therapy devices in patients with heart failure--uprising clinical problem. ].
    Przybylski A
    Kardiol Pol; 2010 Nov; 68(11):1242. PubMed ID: 21108201
    [No Abstract]   [Full Text] [Related]  

  • 2. Heart rates in cardiac resynchronization: the art of optimal device programming.
    Maass AH; van Veldhuisen DJ
    Europace; 2011 Feb; 13(2):157-8. PubMed ID: 21186228
    [No Abstract]   [Full Text] [Related]  

  • 3. Inpatient vs. elective outpatient cardiac resynchronization therapy device implantation and long-term clinical outcome.
    Ajijola OA; Macklin EA; Moore SA; McCarty D; Bischoff KE; Heist EK; Picard M; Ruskin JN; Dec GW; Singh JP
    Europace; 2010 Dec; 12(12):1745-9. PubMed ID: 20852289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of a tool combining guide-wire and stylet for the left ventricular lead positioning.
    Giannola G; Iacopino S; Lombardo E; Cesario A; Di Stefano G; Piraino LG; Campisi G; Torcivia R; Corrao D; Risi A; Denaro A; Valsecchi S;
    Europace; 2011 Feb; 13(2):244-50. PubMed ID: 21131651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary sinus atresia complicating cardiac resynchronization therapy.
    Nakamura T; Otomo K; Kawai S; Igawa O
    J Cardiovasc Electrophysiol; 2010 Oct; 21(10):1178. PubMed ID: 20522151
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute haemodynamic effects of increase in paced heart rate in heart failure patients recorded with an implantable haemodynamic monitor.
    Ståhlberg M; Kessels R; Linde C; Braunschweig F
    Europace; 2011 Feb; 13(2):237-43. PubMed ID: 20952424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [European Society of Cardiology guidelines on cardiac resynchronization therapy].
    Robinet S; Delcour A; Lancellotti P;
    Rev Med Liege; 2014 Apr; 69(4):180-7. PubMed ID: 24923097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical reappraisal of differences in cardiac resynchronization therapy defibrillator effectiveness between men and women in the MADIT-CRT trial.
    Durante A; Cianflone D; Camici PG
    J Am Coll Cardiol; 2011 Jul; 58(4):442-3; author reply 443-4. PubMed ID: 21757127
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiac resynchronization therapy for mild heart failure: the time has come.
    Reynolds CR; Gold MR
    Circulation; 2011 Jan; 123(2):195-202. PubMed ID: 21242505
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiac resynchronization therapy in patients with class I-II heart failure and a wide QRS: a cautionary note.
    Tang WH; Francis GS
    Circulation; 2011 Jan; 123(2):203-8. PubMed ID: 21242506
    [No Abstract]   [Full Text] [Related]  

  • 11. Finding pieces of the puzzle of nonresponse to cardiac resynchronization therapy.
    Gorcsan J
    Circulation; 2011 Jan; 123(1):10-2. PubMed ID: 21173347
    [No Abstract]   [Full Text] [Related]  

  • 12. "Advantage of optimizing V-V timing in cardiac resynchronization therapy devices" by Dr. Duvall.
    Geng J; Zhu J
    Pacing Clin Electrophysiol; 2010 Oct; 33(10):1289-90; author reply 1290-1. PubMed ID: 20718923
    [No Abstract]   [Full Text] [Related]  

  • 13. A device to prevent heart failure is twice as effective in women.
    Harv Womens Health Watch; 2011 May; 18(9):7. PubMed ID: 21818875
    [No Abstract]   [Full Text] [Related]  

  • 14. Left ventricular endocardial leadless pacing brings new hope to patients with heart failure.
    Wang HX; Li XF; Zhang H; Sun S
    Int J Cardiol; 2013 Aug; 167(3):1073-4. PubMed ID: 23168008
    [No Abstract]   [Full Text] [Related]  

  • 15. New developments in cardiac resynchronization therapy.
    Sankaranarayanan R; Visweswariah R; Fox DJ
    Br J Hosp Med (Lond); 2013 Sep; 74(9):503-9. PubMed ID: 24022551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Echocardiographic mapping of left ventricular resynchronization during cardiac resynchronization therapy procedures.
    Chan NY; Choy CC; Cheung KC; Lau CL; Lo YK; Chu PS; Yuen HC; Lau ST; Choi YC
    Chin Med J (Engl); 2010 Jul; 123(13):1645-51. PubMed ID: 20819622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac Resynchronization Therapy in Congestive Heart Failure Patients.
    Williams J
    Can J Cardiovasc Nurs; 2014; 24(3):3-5. PubMed ID: 27356459
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of Cardiac Resynchronization Therapy on Inflammation in Congestive Heart Failure: A Review.
    Lappegård KT; Bjørnstad H; Mollnes TE; Hovland A
    Scand J Immunol; 2015 Sep; 82(3):191-8. PubMed ID: 26099323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New ESC heart failure guidelines with South African expert comment.
    Aalbers J
    Cardiovasc J Afr; 2012 Jun; 23(5):295-6. PubMed ID: 23077733
    [No Abstract]   [Full Text] [Related]  

  • 20. Reducing operator radiation exposure during cardiac resynchronization therapy.
    Brambilla M; Occhetta E; Ronconi M; Plebani L; Carriero A; Marino P
    Europace; 2010 Dec; 12(12):1769-73. PubMed ID: 21097481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.